Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Prevention of T1D in At-Risk Individuals
NCT03428945Phase 2Terminated
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Aug 2018
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of hydroxychloroquine in type 1 diabetes mellitus (T1D), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Aug 2018; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03428945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03428945.